Medical Drugs, Medications Diagnosis, catalog
ANTIDIABETICS AND LEFLUNOMIDE
(A771726) has been shown by
studies to be an inhibitor of CYP2C9, which is concerned with the
. The manufacturers advise caution if
is given with
levels may result.
It may be prudent to monitor blood glucose levels on concurrent use.
Last Updated On: 06/20/2022 (0)